drugset / Trial / NCT04437004

Treatment of Dravet Syndrome With Fenfluramine (Expanded Access Protocol)

NCT04437004

Expanded access Approved for marketing University of California, Los Angeles

Summary

The purpose of this research study is to (1) provide access to fenfluramine for patients with intractable epilepsy associated with Dravet syndrome, and (2) evaluate the safety of fenfluramine.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Fenfluramine Small molecule

Indications